Join to View Full Profile
3333 N Calvert StSte 600Baltimore, MD 21218
Phone+1 410-467-7665
Fax+1 410-467-7746
Dr. Lowentritt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandResidency, Urology, 2001 - 2005- University of MarylandResidency, Surgery, 1999 - 2001
Baylor College of MedicineClass of 1999
Certifications & Licensure
CO State Medical License 2025 - 2027
TN State Medical License 2025 - 2027
MD State Medical License 2005 - 2026
LA State Medical License 2005 - 2012
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Corrigendum to 'Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on ...Benjamin Lowentritt, Dominic Pilon, Ibrahim Khilfeh, Carmine Rossi, Erik Muser
Urologic Oncology. 2025-03-27 - Genomic prostate score and treatment selection in favourable intermediate-risk prostate cancer.Eric Margolis, Benjamin H Lowentritt, Christopher M Pieczonka, John P Bennett, Marina Pavlova
BJUI Compass. 2025-03-01 - How Standard of Truth Methodology Impacts Diagnostic PSMA-Targeting Radiopharmaceutical Evaluation: Learnings from the Phase 3 SPOTLIGHT Study.Benjamin H Lowentritt, Albert Chau, Phillip Davis
Diagnostics. 2025-02-14
Press Mentions
New ERLEADA® (Apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)February 14th, 2022- (Apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence RatesSeptember 12th, 2021
The Latest on Prostate Cancer and Bone Health WebinarOctober 31st, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
